INIS
tumors
100%
infusion
100%
metastases
100%
liver
100%
arteries
100%
patients
43%
cancer
37%
humans
37%
doses
37%
genes
25%
growth
18%
vectors
18%
therapy
18%
tumor cells
18%
gene therapy
18%
death
12%
control
12%
tissues
12%
safety
12%
in vitro
12%
in vivo
12%
adenovirus
12%
design
6%
efficiency
6%
levels
6%
losses
6%
management
6%
diseases
6%
toxicity
6%
clinical trials
6%
stability
6%
dies
6%
pumps
6%
administration
6%
apoptosis
6%
cell proliferation
6%
promoters
6%
Pharmacology, Toxicology and Pharmaceutical Science
Protein P53
100%
Liver Tumor
100%
Neoplasm
50%
Malignant Neoplasm
30%
Colorectal Cancer
30%
Liver Metastasis
30%
Adenoviridae
20%
Tumor Suppressor Protein
10%
Clinical Trial
10%
Cancer Mortality
10%
Tumor Growth
10%
Pharmacokinetics
10%
Human Cytomegalovirus
10%
Route of Administration
10%
Liver Dysfunction
10%
Metastatic Colorectal Cancer
10%
Contusugene Ladenovec
10%
Adenovirus Vector
10%
Disease
10%
Maximum Tolerated Dose
10%